Bench-to-bedside review: Vasopressin in the management of septic shock
Open Access
- 1 January 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 15 (4), 226-19
- https://doi.org/10.1186/cc8224
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Vasopressin Deficiency and Vasodilatory State in End-Stage Liver DiseaseJournal of Cardiothoracic and Vascular Anesthesia, 2011
- Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental studyCritical Care, 2010
- Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptorsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot studyCritical Care, 2009
- Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in miceCritical Care, 2009
- The influence of corticosteroids on the release of novel biomarkers in human endotoxemiaIntensive Care Medicine, 2007
- The Hypothalamic-Pituitary-Adrenal Axis Response to Stress in Mice Lacking Functional Vasopressin V1b ReceptorsEndocrinology, 2007
- Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertensionHepatology, 1998
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992